pyridoxal has been researched along with Benign Neoplasms in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vanadium compounds can exert anticancer effects, partly due to inhibition of tyrosine phosphatases." | 1.39 | Therapeutic potential of a pyridoxal-based vanadium(IV) complex showing selective cytotoxicity for cancer versus healthy cells. ( Basile, A; Mazzone, A; Morello, S; Pellecchia, C; Strianese, M; Turco, MC, 2013) |
| "Suramin was used to analyze the growth-effects of blockade of iron uptake on two established human cell lines, U-937 (monocytoid) and K-562 (erythroleukemic)." | 1.27 | Role of iron in the proliferation of the established human tumor cell lines U-937 and K-562: effects of suramin and a lipophilic iron chelator (PIH). ( Bjelkenkrantz, K; Forsbeck, K; Nilsson, K, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qi, J | 1 |
| Zheng, Y | 1 |
| Li, B | 1 |
| Ai, Y | 1 |
| Chen, M | 1 |
| Zheng, X | 1 |
| Strianese, M | 1 |
| Basile, A | 1 |
| Mazzone, A | 1 |
| Morello, S | 1 |
| Turco, MC | 1 |
| Pellecchia, C | 1 |
| Kovacevic, Z | 1 |
| Yu, Y | 1 |
| Richardson, DR | 4 |
| CHRISTENSEN, HN | 2 |
| RIGGS, TR | 1 |
| COYNE, BA | 1 |
| PAL, PR | 1 |
| Milnes, K | 1 |
| Mason, RP | 1 |
| Forsbeck, K | 1 |
| Bjelkenkrantz, K | 1 |
| Nilsson, K | 1 |
3 reviews available for pyridoxal and Benign Neoplasms
| Article | Year |
|---|---|
Therapeutic potential of iron chelators in cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Deferoxamine; Humans; Iron; Iron Chelating Agents; Isoni | 2002 |
Analogues of pyridoxal isonicotinoyl hydrazone (PIH) as potential iron chelators for the treatment of neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Transport; Carrier Proteins; Cell Division; Humans; Iron | 1998 |
Transmembrane pH gradients in vivo: measurements using fluorinated vitamin B6 derivatives.
Topics: Animals; Fluorescence; Fluorine Radioisotopes; Forecasting; Humans; Hydrogen-Ion Concentration; Magn | 1999 |
7 other studies available for pyridoxal and Benign Neoplasms
| Article | Year |
|---|---|
Pyridoxal hydrochloride thiosemicarbazones with copper ions inhibit cell division via Topo-I and Topo-IIÉ‘.
Topics: Antineoplastic Agents; Cell Division; Copper; DNA Topoisomerases, Type II; Humans; Ions; Ligands; Ne | 2022 |
Therapeutic potential of a pyridoxal-based vanadium(IV) complex showing selective cytotoxicity for cancer versus healthy cells.
Topics: Acetylcysteine; Caspases; Cell Death; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitu | 2013 |
Chelators to the rescue: different horses for different courses!
Topics: Aldehydes; Animals; Deferoxamine; Humans; Hydrazones; Iron Chelating Agents; Iron Overload; Isoniazi | 2011 |
Effects of pyridoxal and indoleacetate on cell uptake of amino acids and potassium.
Topics: Amino Acids; Antifibrinolytic Agents; Indoleacetic Acids; Neoplasms; Potassium; Pyridoxal; Vitamin B | 1954 |
Uptake of pyridoxal and pyridoxal phosphate by Ehrlich ascites tumor cells.
Topics: Animals; Carcinoma, Ehrlich Tumor; Coenzymes; Humans; Neoplasms; Pyridoxal; Pyridoxal Phosphate; Vit | 1961 |
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
Topics: Antineoplastic Agents; Apoptosis; Benzaldehydes; Cell Cycle; Cell Division; Deferoxamine; DNA Fragme | 1997 |
Role of iron in the proliferation of the established human tumor cell lines U-937 and K-562: effects of suramin and a lipophilic iron chelator (PIH).
Topics: Cell Cycle; Cell Division; Cell Line; DNA; Humans; Intracellular Membranes; Iron; Iron Chelating Age | 1986 |